Skip to main content

Healthcare MSO Market Size 2027: Industry Evolution and Technological Advancements

A Healthcare Management Service Organization (MSO) is a health care specific company that provides non-clinical services (administrative and management services) to medical practices, healthcare providers, and ambulatory care facilities.

Advantages Offered by MSOs Fuels Its Demand

A MSO is beneficial to a health system in numerous ways:

  • Improved Quality and Better Efficiency: Due to a common governance structure care management delivery across the organization is standardized. Population health reporting and analytics member identification, risk stratification, attribution, care management delivery, and staffing are all streamlined, which in turn results in performance improvement and better utilization
  • Economies of Scale: MSOs urge the health systems to scout for partnerships, increase membership, and cut per-member-per-month (PMPM) management expenses by creating economies of scale
  • Network Expansion: MSOs offer a competitive edge to healthcare organizations as they relieve them from performing administrative and managerial responsibilities. MSOs serve as an incentive for health organizations that are looking to expand their network

"MSO ensures access to the lowest prices of medical supplies and services... MSOs aggregate volumes and hence are able to achieve economies of scale, which in turn allows them to obtain preferred pricing on medical supplies, healthcare insurance, etc."

  • CEO, Leading Healthcare MSO, U.S.

Foray of Next-Generation MSOs in Orthopedics – An Emerging Trend

Orthopedic physician practices often face challenges such as high overhead costs, deteriorating payments, increased regulatory requirements, and payer and administrative hurdles. On average, orthopedic physician practices spend ~ 50% of their revenue on overheads. To overcome these challenges, a new type of MSOs have ventured into the market that not only provides orthopedic physician practices the tools they need to streamline business functions but also provides technical expertise to succeed.

For instance, in June 2022, a coalition of leading independent orthopaedic and musculoskeletal (MSK) specialists announced the launch of MedVanta, nation's largest physician-owned and operated musculoskeletal management services organization. MedVanta offers next-generation MSO strategies, people, processes, technology and solutions to independent orthopaedic and MSK practices for transforming business operations.

Healthcare Management Service Organization (MSO) Market

Fill out the "Quick Inquiry Form" to request a sample copy

Growing Investments by Private Equity Firms Drive the Market

Citing the lucrative prospects of the market, several private equity companies have also invested in the Healthcare MSO Market.

  • For instance, in April 2023, TPG and AmerisourceBergen Corporation agreed to acquire OneOncology. OneOncology is one of the fastest-growing oncology MSO in the United States
  • In Feb 2021, Cimarron Healthcare Capital, a private equity firm focused on making investments in healthcare companies completed the acquisition of CareAccess MSO. CareAccess MSO partners with primary care physician groups in support of establishing and managing value-based risk contracts with Medicare Advantage plans

Competitive Landscape

Some of the key players operating in the market include MedVanta, Envolve Health, OneOncology,  Vanguard Health Solutions, Neolytix , Argusmso, among others.

The Healthcare Management Service Organization (MSO) Market is expected to gain further momentum in the coming years due to rising focus on value-based care, foray of next-generation MSOs, growing emphasis on improving patient experience, rising investments in patient engagement tools, and aggressive organic and inorganic growth strategies followed by the players





Labels:

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more